Ertl Andrew C, Mann Stephnie, Richardson Antoinette, Briscoe Vanessa J, Blair Hannah B, Tate Donna B, Davis Stephen N
Division of Diabetes, Endocrinology and Metabolism, Dept. of Medicine, 7465 MRB IV, Nashville, TN 37232-0475, USA.
Am J Physiol Endocrinol Metab. 2008 Sep;295(3):E618-25. doi: 10.1152/ajpendo.90470.2008. Epub 2008 Jul 8.
The effects of oral carbohydrate on modulating counterregulatory responses in humans remain undecided. This study's specific aim was to determine the effects of oral carbohydrate on autonomic nervous system (ANS) and neuroendocrine responses during hyperinsulinemic hypoglycemia and euglycemia. Nineteen healthy volunteers were studied during paired, single blind experiments. Nine subjects underwent two-step glucose clamps consisting of 60 min of euglycemia (5.0 mmol/l) followed by either 15 g of oral carbohydrate (cal) as orange juice or a noncaloric control (nocal) and subsequent 90 min of clamped hypoglycemia (2.9 mmol/l). Ten other subjects underwent two randomized 150-min hyperinsulinemic-euglycemic clamps with cal or nocal control administered at 60 min. Oral carbohydrate initially blunted (P < 0.05) epinephrine, norepinephrine, cortisol, glucagon, pancreatic polypeptide, muscle sympathetic nerve activity (MSNA), symptom, and systolic blood pressure responses during hypoglycemia. However, by the end of 90 min of hypoglycemia, plasma epinephrine and norepinephrine responses had rebounded and were increased (P < 0.05) compared with control. MSNA and cortisol levels remained suppressed during hypoglycemia (P < 0.05) after cal, whereas pancreatic polypeptide, glucagon, symptom, and blood pressure responses increased similar to control following initial suppression. Oral carbohydrate had no effects on neuroendocrine or ANS responses during hyperinsulinemic euglycemia. These results demonstrate that oral carbohydrate can have differential effects on the time course of ANS and neuroendocrine responses during hypoglycemia. We conclude that gastro-splanchnic-portal sensing of an amount of carbohydrate recommended for use in clinical practice for correction of hypoglycemia can have widespread and significant effects on central nervous system mediated counterregulatory responses in healthy humans.
口服碳水化合物对调节人体对抗调节反应的影响尚无定论。本研究的具体目的是确定口服碳水化合物在高胰岛素血症性低血糖和血糖正常期间对自主神经系统(ANS)和神经内分泌反应的影响。在配对单盲实验中对19名健康志愿者进行了研究。9名受试者接受了两步葡萄糖钳夹实验,包括60分钟的血糖正常期(5.0 mmol/l),随后给予15克作为橙汁的口服碳水化合物(cal)或无热量对照物(nocal),以及随后90分钟的钳夹低血糖期(2.9 mmol/l)。另外10名受试者接受了两次随机的150分钟高胰岛素血症-血糖正常钳夹实验,在60分钟时给予cal或nocal对照物。口服碳水化合物最初减弱了(P < 0.05)低血糖期间肾上腺素、去甲肾上腺素、皮质醇、胰高血糖素、胰多肽、肌肉交感神经活动(MSNA)、症状和收缩压反应。然而,到低血糖90分钟结束时,血浆肾上腺素和去甲肾上腺素反应出现反弹,与对照组相比有所增加(P < 0.05)。cal后低血糖期间MSNA和皮质醇水平仍受到抑制(P < 0.05),而胰多肽、胰高血糖素、症状和血压反应在最初受到抑制后与对照组相似增加。口服碳水化合物在高胰岛素血症性血糖正常期间对神经内分泌或ANS反应无影响。这些结果表明,口服碳水化合物在低血糖期间对ANS和神经内分泌反应的时间进程可能有不同影响。我们得出结论,临床上推荐用于纠正低血糖的一定量碳水化合物的胃肠-内脏-门静脉感知,可对健康人体内中枢神经系统介导的对抗调节反应产生广泛而显著的影响。